Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
about
Dehydroepiandrosterone for systemic lupus erythematosusThe influence of endogenous and exogenous sex hormones on systemic lupus erythematosus in pre- and postmenopausal womenEnvironmental exposures and the development of systemic lupus erythematosusOptimal management of fatigue in patients with systemic lupus erythematosus: a systematic review.Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays.Gender-specific asthma treatment.Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritisRenal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?Lupus nephritis: a review of the current pharmacological treatments.Challenges in bringing the bench to bedside in drug development for SLE.Emergence of targeted immune therapies for systemic lupus.Emerging drug therapies for systemic lupus erythematosus.Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus.Pharmacotherapy of systemic lupus erythematosus.Update on emerging drug therapies for systemic lupus erythematosus.Management of systemic lupus erythematosus in Chinese patients.Measuring outcomes in systemic lupus erythematosus clinical trials.Dehydroepiandrosterone (DHEA): hypes and hopes.The evolution of drug discovery in systemic lupus erythematosus.A critical review of clinical trials in systemic lupus erythematosus.Immunomodulators in SLE: Clinical evidence and immunologic actions.Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study.Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study.Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration.Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.Predictors of corticosteroid tapering in SLE patients: the Hopkins Lupus Cohort.Response to: 'belimumab and the measurement of fatigue' by Mazzoni.DHEA supplementation of systemic glucocorticoids for treatment of poison ivy dermatitis.Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.Androgen-Induced Immunosuppression.
P2860
Q24243533-855057F0-D1AF-4521-BFC0-75AF7EDE5B92Q26795584-CC536915-80BD-42FC-9CA5-98BC451434A2Q28385351-BCDF4C08-2149-48C0-A649-EE55838ED207Q34351248-3723F8B6-247A-499A-8A86-5963B58E96EEQ34392717-6B55A7C7-32FB-43AE-B267-FF72621436EAQ34709926-C7913B41-1861-4EF2-B262-4CB315C1C329Q35553688-B656F6FA-C963-4A8F-8861-7C8E88ECEA72Q35554324-927A39C4-AEED-4E24-B217-22AF2961FFA0Q35554437-E8A25F6E-5D03-4AB9-B7B0-9BA563990A14Q35824537-D9B63804-F017-43A2-95E1-FBEBEACA6025Q35925513-C8A06A1F-7AF3-4245-A92E-5777B7D9BFCDQ35968394-0A813964-3339-4F02-81DE-3319619AFA41Q36066014-51CD2AEB-3AA1-4A25-854D-FA88B3144AA8Q36634248-001771E1-43EC-4C7E-9A64-A09F0CEF1AE6Q37456307-193C6D76-D07F-44E0-92C9-6255882F25BCQ37504605-DD9AB00A-633A-4EBA-8E69-C37889F6A25AQ37510905-72614CAA-9670-4716-9921-DB60BE4FAAC2Q37690745-1F2BC917-48B3-4CA4-9C0E-904C59FB9F13Q37754815-8745AB5A-342E-41AD-B1B5-0EA8CD5F1AC5Q37914899-C7C37337-F560-45A8-8983-CE9D9F9A5CBBQ38229306-D90D9884-51A6-474B-ABB9-D71CFCE898F8Q38540167-53ACC25A-12F6-4903-BAF8-87ECB86F8F38Q38833868-F218B5D0-891B-4E33-87D6-6B7D597B24A1Q38883883-1EA2D9F1-C2FA-4E58-ADAA-D1D0D2EB9BE3Q39218839-D176B387-75C6-49D7-9A28-87342B20B863Q43041708-9FEA43DE-A8D6-40EA-8EA7-1C2347A3ACA8Q44299617-1E64C395-EE6A-4197-9615-5AFE0C975563Q44412440-F898F824-F4A9-49A6-BC6E-A9881732C122Q45034864-95F08820-7822-44F6-850D-F740F613856AQ45740730-3A6BA538-CA55-43B4-946B-3294390F180FQ46254756-E0D0CC1F-3070-42DF-A27A-808E7320D661Q46841616-939CBB76-1252-4DD9-827C-7BB385952281Q46864446-7C5E4AA2-2726-4FAF-AD46-6300E18FD218Q55357541-BEAFF861-58E4-42C0-9DC8-24B21C9B3449
P2860
Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Effects of prasterone on corti ...... zed, placebo-controlled trial.
@en
Effects of prasterone on corti ...... zed, placebo-controlled trial.
@nl
type
label
Effects of prasterone on corti ...... zed, placebo-controlled trial.
@en
Effects of prasterone on corti ...... zed, placebo-controlled trial.
@nl
prefLabel
Effects of prasterone on corti ...... zed, placebo-controlled trial.
@en
Effects of prasterone on corti ...... zed, placebo-controlled trial.
@nl
P2093
P2860
P356
P1476
Effects of prasterone on corti ...... zed, placebo-controlled trial.
@en
P2093
Arlene Kunz
Ellen M Ginzler
GL601 Study Group
Joan T Merrill
Kenneth E Schwartz
Kenneth J Gorelick
Michael Schiff
Robert G Lahita
Ronald F Van Vollenhoven
Vibeke Strand
P2860
P304
P356
10.1002/ART.10364
P577
2002-07-01T00:00:00Z